Cargando…

Quinine plus clindamycin vs artemether-lumefantrine for treatment of uncomplicated falciparum malaria in western Kenya

Detalles Bibliográficos
Autores principales: Obonyo, Charles O., Ogutu, Bernhards R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214994/
https://www.ncbi.nlm.nih.gov/pubmed/35729571
http://dx.doi.org/10.1186/s12936-022-04222-6
_version_ 1784731119707488256
author Obonyo, Charles O.
Ogutu, Bernhards R.
author_facet Obonyo, Charles O.
Ogutu, Bernhards R.
author_sort Obonyo, Charles O.
collection PubMed
description
format Online
Article
Text
id pubmed-9214994
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-92149942022-06-23 Quinine plus clindamycin vs artemether-lumefantrine for treatment of uncomplicated falciparum malaria in western Kenya Obonyo, Charles O. Ogutu, Bernhards R. Malar J Response BioMed Central 2022-06-21 /pmc/articles/PMC9214994/ /pubmed/35729571 http://dx.doi.org/10.1186/s12936-022-04222-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Response
Obonyo, Charles O.
Ogutu, Bernhards R.
Quinine plus clindamycin vs artemether-lumefantrine for treatment of uncomplicated falciparum malaria in western Kenya
title Quinine plus clindamycin vs artemether-lumefantrine for treatment of uncomplicated falciparum malaria in western Kenya
title_full Quinine plus clindamycin vs artemether-lumefantrine for treatment of uncomplicated falciparum malaria in western Kenya
title_fullStr Quinine plus clindamycin vs artemether-lumefantrine for treatment of uncomplicated falciparum malaria in western Kenya
title_full_unstemmed Quinine plus clindamycin vs artemether-lumefantrine for treatment of uncomplicated falciparum malaria in western Kenya
title_short Quinine plus clindamycin vs artemether-lumefantrine for treatment of uncomplicated falciparum malaria in western Kenya
title_sort quinine plus clindamycin vs artemether-lumefantrine for treatment of uncomplicated falciparum malaria in western kenya
topic Response
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214994/
https://www.ncbi.nlm.nih.gov/pubmed/35729571
http://dx.doi.org/10.1186/s12936-022-04222-6
work_keys_str_mv AT obonyocharleso quinineplusclindamycinvsartemetherlumefantrinefortreatmentofuncomplicatedfalciparummalariainwesternkenya
AT ogutubernhardsr quinineplusclindamycinvsartemetherlumefantrinefortreatmentofuncomplicatedfalciparummalariainwesternkenya